Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China
Pacific Biosciences Grants Equity Incentive Award to New Employee
Amendment: Trading by management and close relations of management
Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021
Read the rest here:
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
View original post here:
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
MedMira Announces Product Update
Go here to read the rest:
MedMira Announces Product Update
Chalice Farms to Launch “Holiday in Color” Pre-Roll Packs, Festive Promotions through Holiday Season
Baudax Bio Announces Publication of ANJESO® Network Meta-Analysis in the Peer-Reviewed Journal BMC Anesthesiology
Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for its Cannabis (CBD & CBG) Infused Chewing Gum Product Line
Sequana Medical Announces Positive Interim Data From North American Pivotal alfapump® Study (POSEIDON)
Supernus to Participate in Annual Piper Sandler Healthcare Conference
See the original post:
Supernus to Participate in Annual Piper Sandler Healthcare Conference
Catalyst Biosciences Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Cyclacel Pharmaceuticals to Release Third Quarter Financial Results
See the rest here:
Cyclacel Pharmaceuticals to Release Third Quarter Financial Results
Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference
Immutep Granted European Patent for IMP761
Original post:
Immutep Granted European Patent for IMP761
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
Eye IRPL® device specifically designed to treat evaporative dry eye due to meibomian gland dysfunction.]]>
Go here to see the original:
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.